U.S. panel rejects Philip Morris claim iQOS device cuts disease risk

Philip Morris International Inc (PM.N) should not be allowed to claim that its iQOS electronic tobacco device can reduce the risk of tobacco-related diseases compared with cigarettes, an advisory panel to the U.S. Food and Drug Administration said on Thursday.The panel concluded that Philip Morris had not proven that iQOS - a sleek, penlike device that heats tobacco rather than burning it - reduces harm compared with cigarettes.IQOS is used by nearly 4 million people in 30 markets outside the Un